Summary: The Human Experience Podcast interviews Brad Burge of MAPS about the completion of Phase 2 clinical trials into MDMA-assisted psychotherapy for PTSD, MAPS’ Global Psychedelic Dinners fundraising initiative for Phase 3 studies, and the MAPS 30th Anniversary Banquet and Celebration. Burge speaks about the experiences of MDMA-assisted psychotherapy study participants, stating, “We are seeing extremely positive results. We have had quite a few study participants being open to speaking about their experience lately.”
Originally appearing here.
Brad Burge is the Director of Communications and Marketing for MAPS (Multidisplinary association for psychedelic studies). In this episode we go over the stages in which the phase trials are being conducted. We also discuss global psychedelic dinners and the upcoming 30th anniversary dinner for MAPS itself and much more.
Brad Burge earned his B.A. in Communication and Psychology from Stanford University in 2005 and his M.A. in Communication from the University of California, San Diego in 2009. His graduate work focused on the political, scientific, and cultural changes required to make illicit drugs into legitimate medicines. He has also interned for the Drug Policy Alliance and has a longstanding interest in drug policy reform and activism. He began working with MAPS as an intern in 2009, joining the staff in January 2011. Brad is also a consultant, writer, and editor for organizations and individuals working in psychedelic and medical marijuana research, drug policy, and psychedelic therapy. He believes in the importance of communication for sharing knowledge and building community, and is committed to helping people develop honest and responsible relationships with themselves, each other, and their pharmacological tools.